Previous Article | Next Article 
Molecular and Cellular Biology, September 2000, p. 6806-6815, Vol. 20, No. 18
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of the Interaction between the
Nuclease and Reverse Transcriptase Activity of the Yeast
Telomerase Complex
Hongwu
Niu,
Jinqiang
Xia, and
Neal F.
Lue*
Department of Microbiology and Immunology,
W. R. Hearst Microbiology Research Center, Weill Medical
College of Cornell University, New York, New York 10021
Received 15 March 2000/Returned for modification 5 May
2000/Accepted 22 June 2000
 |
ABSTRACT |
Telomerase is a ribonucleoprotein that mediates extension of the
dG-rich strand of telomeres in most eukaryotes. Like telomerase derived
from ciliated protozoa, yeast telomerase is found to possess a tightly
associated endonuclease activity that copurifies with the
polymerization activity over different affinity-chromatographic steps.
As is the case for ciliate telomerase, primers containing sequences
that are not complementary to the RNA template can be efficiently
cleaved by the yeast enzyme. More interestingly, we found that for the
yeast enzyme, cleavage site selection is not stringent, since blocking
cleavage at one site by the introduction of a nonhydrolyzable linkage
can lead to the utilization of other sites. In addition, the reverse
transcriptase activity of yeast telomerase can extend either the 5'- or
3'-end fragment following cleavage. Two general models that are
consistent with the biochemical properties of the enzyme are presented:
one model postulates two distinct active sites for the nuclease and
reverse transcriptase, and the other invokes a multimeric enzyme with
each protomer containing a single active site capable of mediating both
cleavage and extension.
 |
INTRODUCTION |
Telomerase is a ribonucleoprotein
that is responsible for maintaining the terminal repeats of telomeres
in most organisms (1, 2, 28, 37). It acts as an unusual
reverse transcriptase (RT), using a small segment of an integral RNA
component as template for the synthesis of the dG-rich strand of
telomeres (11, 12). DNA synthesis by telomerase in vitro is
primed by oligonucleotides with telomere-like sequences. Depending on
the source, telomerase in vitro can act either processively, adding
many copies of a repeat without dissociating, or nonprocessively,
completing only one telomeric repeat (13, 29, 31).
Telomerase activity has been detected in a wide range of organisms,
including protozoa (2), yeasts (4, 17, 18, 20, 35), mice (31), Xenopus laevis
(22), and humans (25). Genes encoding the RNA and
RT subunit of the enzyme complex have also been cloned for many known
telomerases (2, 3, 5, 8, 16, 18, 24, 26, 34). In addition,
both biochemical and genetic studies point to the existence of
additional protein subunits of telomerase, whose functions remain
to be elucidated (7, 9, 15, 19, 27).
A telomerase-associated nuclease has been identified in
Tetrahymena thermophila, Euplotes crassus,
Saccharomyces cerevisiae, and Schizosaccharomyces
pombe (4, 6, 10, 20, 21, 23, 29). In the case of
Tetrahymena telomerase, the associated nuclease has been
found to remove one or several terminal primer nucleotides prior to
polymerization. Enzyme reconstituted in rabbit reticulocyte lysates
with p133 (the RT subunit) and telomerase RNA retains cleavage
activity, suggesting that the nuclease resides in one of these two
components (5). The nuclease from E. crassus has been thoroughly characterized using a coupled cleavage-elongation assay
(10, 23), which revealed the following salient features: (i)
cleavage proceeds by an endonucleolytic mechanism, (ii) DNA fragments
from the 3' end can be eliminated prior to elongation of the primer by
telomerase, (iii) long stretches of preferably nontelomeric sequences
can be removed by the nuclease, (iv) cleavage occurs preferentially but
not exclusively at the junction of match-mismatch between the primer
and the RNA template, (v) the junction of match-mismatch between the
primer and the RNA template can be positioned at various locations
along the RNA template to effect cleavage, and (vi) primers bearing
nontelomeric sequences at the 5' end are preferentially cleaved. While
not as thoroughly studied, the nuclease from other organisms exhibits
properties consistent with those displayed by the
Tetrahymena and E. crassus enzymes. For example,
both primer-template mismatch and the presence of nontelomeric
sequences at the 5' end have been found to stimulate cleavage by the
yeast telomerase-associated nuclease (21, 29).
Various functions have been suggested for the telomerase-associated
endonuclease. For example, the combined cleavage and elongation activity may be useful in the de novo formation of telomeres during macronuclear development in ciliated protozoa (23).
Alternatively, cleavage may serve a proofreading function given that
nontelomeric sequences appear preferentially removed (10,
23). In addition, by analogy with DNA-dependent RNA polymerases,
cleavages may allow an elongation-incompetent telomerase to re-engage
the 3' end of the primer prior to extension (5).
In this study, we characterized the Saccharomyces cerevisiae
telomerase-associated nuclease in greater detail and found that it
shares many properties that have been ascribed to the ciliate enzymes.
For example, yeast cleavage activity is tightly associated with the
polymerization activity. In addition, primers with sequences that are
noncomplementary to the RNA template appear to be relatively efficient
substrate for cleavage by yeast telomerase. The yeast nuclease also
appears to act through an endonucleolytic mechanism. More surprisingly,
we found that following cleavage, either one of the fragments generated
by the yeast nuclease (the 5' and the 3' fragments) can be extended by
the polymerization activity of telomerase. This result is not easily
rationalized in terms of a monomeric enzyme containing a single
nuclease-polymerase active site. Two models that are compatible with
all of our biochemical observations are presented in the Discussion.
 |
MATERIALS AND METHODS |
Yeast strains, media, buffers, and the preparation of yeast
telomerase.
JX-M3 is a haploid yeast strain identical to W303a
except that the EST2 gene in the strain was fused at its C terminus to a Myc3 epitope tag using a PCR recombination method
(35). JX-MH19 contains an EST2 gene whose C terminus is
fused to both a Myc3 epitope tag and a His6
tag. JX-proA contains an EST2 gene with, in addition to the Myc and His
tags, two copies of the immunoglobulin G (IgG) binding domain from
protein A. The construction of these strains will be described in
detail elsewhere.
Buffer TMG-15 contains 15% glycerol, 10 mM Tris-HCl (pH 8.0), 1.2 mM
magnesium chloride, 0.1 mM EDTA, 0.1 mM EGTA, and 1.5 mM dithiothreitol
(DTT). Buffer TMG-10 is identical to TMG-15 except that glycerol was
included at 10%. Buffer TMG-10(500), etc., denotes buffer TMG-10 plus
the millimolar concentration of sodium acetate specified by the number
in parentheses. The following protease inhibitors were included in all
buffers: 1 mM phenylmethylsulfonyl fluoride, 2 mM benzamidine, 2 µg
of pepstatin A per ml, and 1 µg of leupeptin per ml.
Purification of yeast telomerase.
For preparation of
whole-cell extracts, the yeast strains DG338 (a gift of D. Garfinkel,
National Cancer Institute), W303a, JX-M3, JX-MH19, or JX-proA was grown
in YPD medium, lysed in TMG-15(0) buffer, and the lysates were
clarified by high-speed centrifugation as previously described (4,
21). To obtain active telomerase, whole-cell extracts were
processed over DEAE-agarose columns as previously described (4,
21). For Myc-tag affinity purification, DEAE fractions (10 ml)
prepared from the JX-M3 strain were loaded directly onto a 0.5 ml of
9E10 (Myc antibody) column. The column was washed with TMG-10(500) and
then TMG-10(500) containing 1 mg of HA.11 (hemagglutinin) peptide per
ml at 4°C. Telomerase was then eluted at room temperature with 1.5 ml
of TMG-10(500) containing 1 mg of 9E10 (Myc) peptide per ml. The
overall recovery of activity was ~10%, while 0.05% of the load had
approximately the same amount of total protein as 50% of the purified
fraction, based on the staining of a sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel. Because the
estimate of the protein concentration is not precise, we did not
determine the fold enrichment for telomerase in this immunoaffinity
procedure. For metal affinity purification, DEAE fractions (2 ml)
prepared from JX-MH19 strain were loaded directly onto a 0.2-ml
Ni-nitrilo triacetic acid column (Qiagen). The column was washed
successively with TMG-10(500) and TMG-10(500) containing 5 mM
imidazole. Active telomerase was then eluted with TMG-10(500)
containing 200 and 500 mM imidazole. The majority of telomerase was
present in the 200 mM elution. The overall recovery of activity was
~50%, while the purified fraction contained a fraction (ca. 1/20) of
the starting protein based on the Bio-Rad Protein Assay (Bio-Rad
Laboratories). Thus, we estimate that telomerase is enriched by about
10-fold by the metal affinity procedure. For the protein A-tag-based
purification, a DEAE fraction from JX-proA (100 µl) was directly
incubated with 5 µl of IgG-Sepharose beads at 4°C with gentle
rotation for 2 h. The beads were washed multiple times with
TMG-10(600) and then assayed for telomerase activity along with the
DEAE fraction and the supernatant. More than 95% of the starting
protein remained in the supernatant, while the beads contained ~50%
of the starting activity. Thus, telomerase was purified more than
10-fold by this IgG affinity procedure.
For multistep purification, the protein A-tagged enzyme was
successively fractionated over DEAE, phenyl, heparin, and IgG columns.
DEAE chromatography was carried out as previously described (4,
21). Active fractions from the DEAE column were pooled and loaded
directly onto a phenyl Sepharose (Pharmacia) column. The column was
washed successively with two column volumes each of TMG-10(500) and
TMG-10(100), and the activity was eluted with two column volumes of
TMG-10(0) plus 1% Triton X-100. Active fractions were pooled and
loaded onto an Affi-Gel Heparin (Bio-Rad) column. The column was washed
with two column volumes of TMG-10(150), and the activity was eluted
with two column volumes of TMG-10(700). Active fractions were then
processed over IgG-Sepharose resin as described earlier. The specific
activity and the degree of purification were calculated from primer
extension activity assays and protein assays with two exceptions.
First, because the activity was undetectable in whole-cell extracts,
the fold purification for the DEAE column fraction was based on the
degree of Est2p enrichment (as determined by Western blotting). Second,
because it is not possible to elute telomerase from IgG-Sepharose, we estimated the amount of total protein bound to the beads to be the
difference in protein concentration of the heparin fraction before and
after binding to IgG beads. For Western analysis of protein A-tagged
Est2p, proteins from extracts or DEAE fractions were separated in by
SDS-8% PAGE and transferred onto nitrocellulose membrane. Primary
anti-protein A antibody (Sigma) and secondary antibody were used at
1:1,000,000 and 1:5,000 dilutions, respectively. Immunoreactive species
were visualized using the ProtoBlot system (Promega).
Primer preparation.
DNA primers were purchased from GeneLink
(Thornwood, N.Y.) and gel purified prior to use in polymerization
assays. Crude primers were dissolved in distilled H2O at 1 mg/ml and fractionated on a 16% denaturing polyacrylamide gel.
Full-length DNA fragments were visualized by ethidium bromide staining
and UV transillumination, isolated as small gel slices, and eluted
overnight at 37°C with 400 µl of extraction buffer containing 0.1%
SDS, 0.3 M sodium acetate, 10 mM magnesium acetate, and 1 mM EDTA. The
DNA was recovered from the extraction buffer by ethanol precipitation
in the presence of 5 µg of glycogen and resuspended in a suitable
volume of water. The concentration of the purified DNA primer was again
quantified by PAGE and ethidium bromide staining.
Primers bearing methylphosphonate linkages were also purchased from
GeneLink and then gel purified prior to use. Resistance to nuclease was
confirmed by using Escherichia coli Exonuclease III (New
England Biolabs). Primers terminating in dideoxynucleotides were made
by treating 500 pmol of DNA primer with 34 U of terminal deoxynucleotide transferase (USB; 17 U/µl) and 833 µM
dideoxynucleotides (ddTTP or ddGTP) in 30 µl of total volume
containing 1× buffer (USB) at 37°C for 3 h. After
phenol-chloroform extraction, full-length DNA was recovered by ethanol
precipitation and gel purified as described above.
Coupled cleavage-extension assay.
A standard
cleavage-extension assay (30 µl) contained 50 mM Tris-HCl (pH 8.0), 1 mM spermidine, 1 mM DTT, 1 mM MgCl2, 130 µM dTTP, 1 to 2 µl of [
-32P]dGTP (3,000 Ci/mmol, 10 µCi/µl), and
various amounts of DNA primers and telomerase fractions. Reactions were
started by the addition of telomerase fraction to a premixed cocktail
consisting of all the other components. Reactions were continued for
1 h at 30°C, and labeled products were processed as described
previously (21).
 |
RESULTS |
Observation of a nuclease in yeast telomerase fractions.
For
purification and characterization of yeast telomerase, we utilized a
direct primer extension assay (4, 21). Under standard
reaction conditions, the yeast enzyme is nonprocessive and gives rise
predominantly to a "primer + 3" product
(21; Fig. 1A). Interestingly, the use of certain
primers in extension assays, especially those consisting of repeats
from other organisms, often yielded products that are shorter than the
input primer. For example, when Oxytricha, human, and
Arabidopsis repeats are utilized as primers, as much as 20%
of the labeled products in the polymerization assays were shorter than
the starting primer (Fig. 1A and B). To
rule out the possibility that there is excess nonspecific nuclease in
the partially purified yeast telomerase fractions, we assembled mock
telomerase reactions using the fraction, unlabeled primer, and
unlabeled nucleotide triphosphates. Also included in each reaction was
a small amount of end-labeled tracer oligonucleotide used to monitor
the fate of the input primer. As shown in Fig. 1C, the vast majority of
the starting primers are neither shortened nor extended, even in the
presence dGTP and dTTP. This result is consistent with the large molar
excess of primer over active telomerase as determined by the
polymerization assay. No discrete bands can be visualized in the region
of the gel presumed to contain the nuclease-derived products, and
quantification indicates that this region possesses <2% of the
radioactivity present in the full-length bands. These results are quite
consistent with earlier observations on the existence of a specific
nuclease in yeast telomerase fractions (4, 21, 29).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 1.
Yeast telomerase partially purified by DEAE
chromatography contains a nuclease activity. (A) Polymerization assays
were performed using 5 µM concentrations of various primers and 9 µg of DEAE fractions (Pr.Ext.). Primers labeled by terminal
transferase and cordycepin were run alongside the reaction products as
size standards (+1 Marker). (B) The sequences of the primers used in
panel A. (C) Concentrations (5 µM) of various primers (containing a
small amount of labeled tracer) were incubated alone, with telomerase
fractions, or with telomerase fraction and deoxynucleotide
triphosphates. The DNA was recovered and analyzed by denaturing gel
electrophoresis as in standard primer extension assays.
|
|
Since <2% of the input primers were cleaved yet as much as 20% of
the extension products were derived from cleaved DNA, telomerase appears to preferentially extend cleaved DNA (by at least 10-fold). This preferential extension can be explained by either a coupling between the telomerase and the nuclease or by short primers being intrinsically superior substrates for telomerase. To address the latter
possibility, we assessed the activity of two primers of different
lengths (OXYT1 and OXYT2) bearing the Oxytricha telomeric repeats at increasing primer concentrations. The shorter primer (OXYT2)
was designed to mimic the size of the cleaved but not yet extended DNA
derived from the longer primer (OXYT1). As shown in Fig.
2A, the cleavage-derived products of
OXYT1 are indeed similar in size to the direct extension products of
OXYT2. Furthermore, at the same molar concentration, OXYT1 and OXYT2
supported a nearly identical amount of DNA synthesis, suggesting that
short DNAs are not intrinsically better substrates for yeast telomerase
(Fig. 2B). Therefore, a physical or functional coupling between the nuclease and telomerase appears likely.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
Long and short heterologous primers are utilized by
yeast telomerase at comparable efficiencies. (A) Polymerization assays
were performed using 1.5 µM concentrations of either OXYT1 or OXYT2
as the DNA primer and 2.3 µg of DEAE fractions. The locations of the
"+3" and " 4" products for OXYT1 and that of the "+3"
product for OXYT2 are indicated by horizontal bars. (B) Polymerization
assays were carried out using increasing concentrations of either OXYT1
or OXYT2, and the signals derived from direct extension of the primers
were quantified and plotted.
|
|
Affinity-purified telomerase exhibits the same nuclease
activity.
To determine if the coupling observed between the
nuclease and telomerase in the DEAE fraction can be explained by
physical association, we further purified yeast telomerase using three different affinity tags (a Myc3 tag, a His6
tag, and a protein A tag) and the appropriate chromatographic resins.
All three tags were fused to the C terminus of Est2p and had no effect
on telomere maintenance or telomerase activity (J. Xia and N. F. Lue, unpublished data). The detailed purification procedures and the
estimates for the degrees of enrichment are presented in Materials and
Methods. In each case, the affinity-tagged telomerase was first
purified over a DEAE column (4, 21). Active enzymes were
then adsorbed onto the appropriate affinity columns and either eluted
with specific competitors before analysis (for Myc- and His-tagged
enzymes) or directly assayed on the resin (for protein A-tagged
enzymes). As shown in Fig. 3A, each of
the purification procedures resulted in telomerase that was still
capable of catalyzing the cleavage-extension reaction on the OXYT1
primer. Furthermore, in each case the fraction of the products that
were shorter than the starting primer was similar for both the DEAE and
the affinity-purified enzyme (compare lanes 1 and 2, 3 and 4, and 5 and
6). A contaminating activity (or activities) capable of generating
labeled high-molecular-weight products is evident in DEAE fractions
derived from the Myc- and His-tagged strains (lanes 1 and 3, indicated
by brackets to the left of the panels). This activity (or activities)
was successfully removed by the affinity procedures.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
Affinity-purified yeast telomerase exhibits a similar
cleavage activity as that found in DEAE fractions. (A) Polymerization
assays were carried out using OXYT1 (1 µg) as the DNA primer and DEAE
fraction (DEAE) or affinity-purified telomerase (Affinity) as the
source of telomerase. The affinity resin utilized for each purification
is indicated at the top. The amount of protein used for each reaction
is as follows: lane 1, 3 µg; lane 2, 45 ng; lane 3, 3 µg of
protein; lane 4, 0.4 µg of protein; lane 5, 3 µg of protein; lane
4, ~0.15 µg of protein. "Direct extension" or
"cleavage-derived" products are marked by vertical lines to the
left of the panels. Contaminating activity or activities present in the
DEAE fraction and responsible for the labeling of high-molecular-weight
products (indicated by brackets to the left of the panels) can be
removed by the Myc affinity or the nickel affinity chromatographic
procedures. (B) Immunoblotting was used to estimate the degree of Est2p
enrichment over the DEAE column. Protein A-tagged Est2p from extracts
or DEAE fractions was detected using anti-protein A antibodies. The
amount of protein loaded is indicated at the top. The location of the
protein A-tagged Est2p is indicated by an arrow. (C) Protein
compositions of fractions from successive column steps were analyzed by
SDS-PAGE and silver staining. The identities and the amounts of the
fractions utilized were as follows: lane 1, extract, 30 µg; lane 2, DEAE, 10 µg; lane 3, phenyl, 3 µg; lane 3, heparin, 1.2 µg; lane
4, IgG, ~0.12 µg. (D) Polymerization assays were carried out using
OXYT1 (2 µg) as the DNA primer and fractions from successive column
steps. The identities of the fractions used in each reaction were as
follows: lane 1, DEAE, 10 µg; lane 2, phenyl, 3 µg; lane 3, heparin, 1.2 µg; lane 4, IgG, ~0.12 µg. The ratios of cleavage to
extension products are listed at the top.
|
|
To further eliminate the possibility of an unrelated, contaminating
nuclease, we purified protein A-tagged telomerase using four
consecutive chromatographic steps (DEAE, phenyl, heparin, and IgG; see
Table 1). The degree of purification was
monitored throughout the procedure by protein and activity assays with
two exceptions. First, because the activity was undetectable in
whole-cell extracts, the fold purification for the DEAE column fraction
was based on the degree of Est2p enrichment as determined by Western blotting using anti-protein A antibodies (Fig. 3B). Second, because it
is not possible to elute telomerase from IgG-Sepharose, we estimated
the amount of total protein bound to the beads to be the difference in
protein of the heparin fraction before and after binding to IgG beads.
Changes in the polypeptide compositions of the fractions are evident
during purification (Fig. 3C). However, because of the low abundance of
telomerase in yeast, telomerase-specific polypeptides cannot be
identified even after this multistep purification procedure. When
tested in the primer extension assay (Fig. 3D), the nuclease-derived
products are evident following each chromatographic step, and
PhosphorImager analysis indicates that the ratio of cleavage to
extension products varied by no more than twofold. Based on these
studies, we conclude that cleavage of starting primers by
telomerase fractions is unlikely to be due to an unrelated contaminant.
The effects of reaction parameters on telomerase-mediated primer
cleavage.
To determine if the extent of cleavage is affected by
any reaction parameters, we varied the duration and the concentrations of the components of the reaction. Time course experiments indicate that the "direct extension" and "cleavage derived" products
accumulate with similar kinetics (38), both being complete
within ~15 min. Prolonged incubation does not result in an increase
in the relative amount of the cleavage products. Thus, there appears to
be little nonspecific nuclease in the fraction that can degrade the
labeled products, a finding consistent with the earlier tracer
experiment (Fig. 1C). Increasing the salt concentration also did not
appreciably affect the ratio of the two classes of products (Figure 4A,
lanes 1 to 3). Increasing primer concentration from 3 to 24 µM
reduced the relative amount of cleavage products by threefold,
suggesting that the direct extension reaction pathway is more favorable
at high primer concentrations (Fig. 4A,
lanes 4 to 7). More interestingly, when the total dGTP concentration
was increased by about 10-fold over the standard reaction (to 2 µM),
the cleavage products were almost completely abolished, despite the
presence of a significant amount of direct extension products (Fig. 4B,
lanes 4 and 5). Thus, the cleavage-extension reaction pathway appears
to be favored when the concentration of dGTP is low. Cleavage-derived
products were not evident in some published studies on yeast telomerase (18, 19). This discrepancy is most likely due to the use of different primers and higher nucleotide concentrations in these other
studies. The concentration of dGTP has been reported to affect the
processivity and template utilization of the Euplotes aediculatus telomerase (14). Whether these effects of
dGTP are related to its ability to influence cleavage remains to be
determined.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of salt, primer, and nucleotide concentration on
the coupled cleavage and extension reactions mediated by yeast
telomerase. (A) Polymerization assays were carried out using OXYT1 as
the DNA primer and DEAE column fractions as the source of telomerase.
For reactions 1 to 3, the DEAE fraction was first desalted using
Centricon-30. Sodium acetate was then added to the following final
concentrations: lane 1, 0 mM; lane 2, 150 mM; lane 3, 300 mM. For
reactions 4 to 7, the following concentrations of OXYT1 primer were
used: lane 4, 3 µM; lane 5, 6 µM; lane 6, 12 µM; lane 7, 24 µM.
(B) Polymerization assays were carried out using OXYT1 as the DNA
primer and DEAE column fractions as source of telomerase. In addition
to 0.2 µM labeled dGTP (3,000 Ci/mmol; NEN), unlabeled dGTP was added
to the following concentrations: lane 1, 0 µM; lane 2, 0.5 µM; lane
3, 1.0 µM; lanes 4 and 5, 2.0 µM. Lane 5 represents a longer
exposure than lane 4.
|
|
Primers bearing nontelomeric cassettes are susceptible to cleavage
by telomerase.
Characterization of the ciliate
telomerase-associated nuclease suggests that the cleavage pathway
is affected by primer-RNA interactions (10, 21, 23, 29). In
general, primer-template mismatches can apparently promote cleavage. In
particular, a primer containing a telomeric cassette embedded in
nontelomeric sequences was an especially good substrate for cleavage by
Euplotes telomerase. To determine if the yeast telomerase
nuclease has similar properties, we tested yeast telomeric primers
bearing nontelomeric cassettes at their 5' or 3' end in the
polymerization reactions. As shown in Fig.
5, a primer containing either an 8- or a
14-nucleotide (nt) nontelomere cassette at its 5' end (TEL51 and TEL52)
was efficiently extended by telomerase. Such primers also gave rise to
a significant amount of "cleavage-derived" products. Interestingly, the size of the cleavage-derived products was similar for these two
primers (Fig. 5B, compare lanes 1 and 3). This result suggests that
cleavage might have occurred predominantly near the junction of the
telomeric and nontelomeric cassettes, thereby releasing telomeric
fragments of similar size to be extended by the RT. If this conjecture
is true, then telomerase is not only capable of extending the 5'
cleavage fragment, as previously reported, but also the 3' fragment.
This possibility was confirmed in experiments reported in the following
sections.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of flanking nontelomeric cassettes in the DNA
primer on cleavage and extension by yeast telomerase. (A) The sequences
of the oligonucleotides used for the assays in panel B. The telomeric
portion of the primer is underlined. (B) Polymerization assays were
carried out using DEAE column fractions as a source of telomerase and
various primers as indicated at the top of the panel. The reactions
were carried out in the absence or presence of RNase A as indicated at
the bottom of the panel. The sizes of the various products in relation
to TEL51 (as determined in a separate assay) are indicated to the left,
while the regions of the gel containing the direct-extension and
cleavage-derived products are indicated by vertical lines to the right
of the panel.
|
|
In contrast to primers with 5' nontelomeric cassettes, primers with the
same two cassettes at their 3' end (TEL106 and TEL107) were poor
substrates for telomerase-mediated extension, and few cleavage products
could be observed in these reactions. As expected, the 14-nt
nontelomere cassette on its own failed to yield any extension product (TEL108).
The yeast telomerase-associated nuclease acts
endonucleolytically.
The cleavage-derived products for most
primers had a nonrandom distribution. For example, for both HS2 and
OXYT1, the cleavage-derived products were most prominent around the
"primer-4" position (Fig. 6B, lanes 1 and 5). This suggests that the telomerase-associated nuclease cleaved
DNA preferentially at internal locations, acting as an endonuclease.
However, one can also postulate that an exonuclease was responsible and
that preferential stalling of the nuclease at particular locations or
preferential extension of cleavage products bearing optimal 3'-end
sequences gave rise to the observed pattern of product synthesis. To
distinguish between these alternatives, we carried out polymerization
reactions using primers derivatized with methylphosphonate linkages
(Fig. 6A). This modification was expected to render the phosphodiester
bond resistant to nuclease attack. If an exonuclease was responsible
for the observed primer degradation, the placement of a
methylphosphonate linkage between the 3'-most two bases should inhibit
the formation of all of the short products. In contrast, if an
endonuclease was responsible, then the predominant short products
(e.g., the "primer-4" band) should be unaffected because the
cleavage that resulted in these products should have occurred far away
from the modified linkages.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of methylphosphonate linkages in the DNA primer
on cleavage and extension by yeast telomerase. (A) The regular and
derivatized oligonucleotides used for the reactions in panel B are
listed. The location of the methylphosphonate linkage is denoted by an
asterisk. (B) Polymerization assays were carried out using 0.5 µg of
the various primers as indicated at the top and either 5 µg (lanes 1 to 4) or 3 µg (lanes 5 to 8) of the DEAE fraction. The lengths of the
labeled products relative to the starting primers are indicated by
lines and numbers to the left of the panels. (C) A schematic
illustration of the cleavage-elongation pathways that can account for
the reaction products visualized in lanes 1 and 2 of panel B. The
nuclease is proposed to act endonucleolytically and to act
predominantly in the middle G tract. As described in the text, yeast
telomerase strongly prefers to extend primers that have three Gs at
their 3' end and extends these primers predominantly by 3 nt. Thus,
reaction a generates two fragments that can both be efficiently
extended, leading to the synthesis of the primer-3 and primer-6
products. Reactions b and c each generate only one efficient substrate,
leading to the synthesis of the primer-5 and primer-4 products. The
methylphosphonate substitution in MP-1 (marked by an asterisk) strongly
inhibits extension of the nearby 3' OH group by telomerase, causing the
loss of the "+3" product as well as the " 4," " 5," and
" 6" products.
|
|
As shown in Fig. 6B, some of the cleavage-derived products were
retained despite the substitution of one of the two 3'-most phosphodiester linkages of the HS2 or the OXYT1 primer (the HS2-MP1, HS2-MP2, OXYT1-MP1, and OXYT1-MP2 oligonucleotides). These observations suggest that some of the short products must be generated by an endonuclease, as in the case of the Euplotes
telomerase-mediated cleavage. Close inspection of the reaction products
derived from modified HS2 oligonucleotides revealed two interesting
features. First, the amount of "direct extension" products (as
evidenced by the intensity of the "primer + 3" band) was
greatly inhibited by a methylphosphonate at the 3'-most linkage (Fig.
6B, compare lane 2 with lane 1). This suggests that the last
phosphodiester linkage of the primer may make a functionally important
interaction with telomerase, which can be disrupted by the
modification. Methylphosphonate linkages positioned near the 3' end has
also been found to inhibit extension by E. crassus
telomerase (D. E. Shippen, personal communication). Second, the
"primer-4" and "primer-5" products were almost completely abolished (Fig. 6B, compare lane 2 with lane 1), just like the direct
elongation products. This similarity suggests that the primer-4
and primer-5 products may also be derived from primers with
methylphosphonate modification near the 3' end. In other words, these
products may be due to extension of the 3' cleavage products. In
contrast, the "primer-3" product was virtually unaffected, suggesting that it may be derived from the 5' fragment generated by the nuclease.
Extensive characterization of primer utilization by yeast
telomerase indicates that the enzyme preferentially extends
oligonucleotides with 3 Gs at their 3' end. Furthermore, in our
reaction condition, the enzyme has a strong tendency to pause or
dissociate after adding 3 nt (TGT) (21; Xia and Lue,
unpublished). Taking this property of telomerase into consideration, we
can account for all of the cleavage-elongation products of HS2 by the
hypothetical scheme presented in Fig. 6C. In this model, cleavage
occurs preferentially in the middle G tract. Cleavage between the ninth
and tenth nucleotides of HS2 (reaction a) leads to the creation of a 5'
fragment (GGGTTAGGG) that is expected to be a good substrate
for telomerase and to yield a predominant 12-nt product
(GGGTTAGGGTGT) at the primer-3 location, precisely as was
observed. The same cleavage should also give rise to a 3' fragment
(TTAGGG) that can yield a 9-nt product (TTAGGGTGT)
at the primer-6 position. This was also observed. Cleavage
between the eighth and ninth nucleotides (reaction b) and between the
seventh and eighth nucleotides (reaction c), on the other hand, would
yield 5' fragments that are poor substrate for telomerase but 3'
fragments that are good substrates (GTTAGGG and
GGTTAGGG). These 3' fragments are expected to give rise
predominantly to the primer-5 and primer-4 products, respectively. An
important prediction of this scheme is that the extension products of
the 3' fragments (primer-4, primer-5, and primer-6) should be inhibited by the MP1 modification, while the extension products of the 5' fragment (primer-3) should not. This prediction was entirely consistent with the observation made here (Fig. 6B, compare lanes 2 and 1). A
similar argument can be made to account for the cleavage-elongation products of the OXYT1 primer if cleavages occur predominantly in the
middle G tract.
Flexibility of the nuclease cleavage site.
To test if the
predicted cleavage sites were in fact utilized by yeast telomerase, we
designed primers (HS2-MP3 and OXYT1-MP3) to specifically render one of
the linkages nonhydrolyzable. Both MP3 modifications abolished some but
not all of the reaction products, as expected (Fig. 6B, compare lanes 1 and 4 and lanes 5 and 8). More interestingly, the OXYT1-MP3
oligonucleotide gave rise to some products that are not observed in the
case of OXYT1. Thus, for OXYT1-MP3, the primer-2 and primer-3 bands are
stronger than the primer-4 band, a finding that was precisely the
reverse of the pattern for OXYT1 (lanes 5 and 8). These results suggest
the interesting possibility that when a preferred cleavage site is resistant to the nuclease, other sites can be utilized, leading to a
different distribution of fragments.
Extension of either the 5' or the 3' cleavage products by yeast
telomerase.
Both the nontelomeric cassette study (Fig. 5) and the
methylphosphonate substitution study (Fig. 6) suggest that either the 5' or the 3' fragment generated by the nuclease can be extended by the
RT activity of telomerase. To confirm this conjecture, DNA primers
terminating in dideoxynucleotides were synthesized by using terminal
transferase and the appropriate dideoxynucleotide triphosphates and
then subjected to the extension assay. All products resulting from the
addition of nucleotides to the 3' cleavage fragment were expected to be
abolished by this modification, while those from the addition of
nucleotides to the 5' cleavage fragment should be unaffected.
Primers containing nontelomeric cassettes (Fig. 5), as well as primers
containing heterologous repeats (Fig. 1, 4, and 6), were tested in this
assay. As shown Fig. 7A, when primers
bearing 5' nontelomeric and 3' telomeric cassettes were utilized, all of the direct extension products can be abolished by substituting the
last nucleotide of the primer with
dideoxynucleotide, as expected. More
significantly, the cleavage-derived products can also be entirely
abolished by substituting the last nucleotide of the primer with
dideoxynucleotide. However, when the same analysis was applied to
primers bearing heterologous telomeric repeats, different results were
obtained. For example, substitution of the last dG residue of OXYT1
with ddG eliminated some but not all of the cleavage-derived products
(Fig. 7B, lanes 1 and 3). Substitution of the last dG residue of HS2
with ddG had similar effects (Fig. 7B, lanes 5 and 7). Most
importantly, in the case of OXYT1 and HS2 the cleavage products
eliminated by the ddGMP modification are precisely those eliminated by
the MP1 modification, a finding consistent with the notion that both
modifications abolished labeling of the 3' cleavage fragment. For
example, the OXYT1-ddG oligonucleotide yielded the prominent primer-4
product (indicated by a closed circle in lane 3) but not the primer-5
or primer-6 products evident in the case of the OXYT1 oligonucleotide
(indicated by open circles in lane 3). This was precisely what was
observed for the OXYT1-MP1 oligonucleotide. The same comparison can be made between the products generated by HS2-ddG and HS2-MP1
oligonucleotides (compare lane 7 of Fig. 7B and lane 2 of Fig. 6B). As
expected for telomerase-mediated extension, all of the cleavage-derived products from either the native or the ddG-modified primers were sensitive to RNase A pretreatment (lanes 2, 4, 6, and 8). Taken together, the dideoxy substitution experiments suggest that in the case
of primers containing nontelomeric cassettes, telomerase appears to
preferentially extend the 3' cleavage fragment, while in the case of
primers containing heterologous repeats, telomerase appears to be
capable of extending both the 5' and the 3' fragments derived from
cleavage.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
Effects of 3' dideoxynucleotide substitutions in the DNA
primer on cleavage and extension by yeast telomerase. (A)
Polymerization reactions were carried out using 160 ng (lanes 1 to 4)
or 400 ng (lanes 5 to 8) of the DNA primers (as indicated at the top of
the panels) and 5 µg of the DEAE fractions. The primers bear either a
deoxy- or a dideoxynucleotide at their 3' termini. The sequences of the
oligonucleotides used are shown at the top, and the GT-rich (yeast
telomere-like) parts of the oligonucleotides are underlined. (B)
Polymerization reactions were carried out using 0.5 µg of the DNA
primers (as indicated at the top of the panel) and 5 µg of the DEAE
fractions. The primers used in lane 3, 4, 7, and 8 bear
dideoxynucleotides at their 3' ends. RNase A was added to the reactions
in lanes 2, 4, 6, and 8. Products derived from direct extension or
cleavage followed by extension (cleavage derived) are indicated by
vertical bars to the left of the panels. Bands unaffected or abolished
by the dideoxynucleotide substitution are indicated by closed or open
circles, respectively.
|
|
 |
DISCUSSION |
We have shown that, like ciliate telomerases, yeast telomerase
has a tightly associated endonuclease activity that can cleave the
starting primer prior to extension by the RT subunit. Novel aspects of
this work include the demonstration (i) that the nuclease can be
affinity purified along with the RT subunit of telomerase, (ii) that
both the 5' and the 3' fragments derived from cleavage can be extended
by telomerase, and (iii) that the loss of one nuclease site can lead to
the preferential utilization of other sites.
The ability of yeast telomerase to extend either one of the cleaved
fragments is somewhat surprising in light of earlier studies showing
that extension occurs mostly on the 5' fragment (23). This
discrepancy is most likely explained by the use of primers bearing 3'
nontelomeric cassettes in these earlier studies. Such nontelomeric
cassettes, once released from the rest of the primers, are probably
inefficient substrates for telomerase extension. Indeed, for
primers that bear a 5' nontelomeric cassette and a 3' telomeric
cassette, the cleavage-derived products are all due to labeling of the
3' fragments, a result consistent with the 3' telomeric cassettes being
better substrates for yeast telomerase than the 5' nontelomeric
cassettes. Similarly, the ability of yeast telomerase to extend both of
the fragments derived from cleavage of heterologous repeats is
explained by both fragments' ability to form a hybrid with the RNA
template and serve as a substrate for extension.
Initial studies of the Tetrahymena enzyme revealed
similarities between RNA polymerase-mediated transcript cleavage and
telomerase-mediated primer cleavage (5, 36). Such
observations raise the interesting possibility that telomerase uses the
polymerization site to carry out the cleavage reaction. (The evidence
that RNA polymerase mediates transcript cleavage through the
polymerization active site is compelling [32]). In
this model, one would expect telomerase to extend exclusively the 5'
fragment, because the 3'-OH group of this fragment would be located
optimally at the polymerase active site immediately following cleavage.
This expectation is clearly not met by our results.
To account for the ability of yeast telomerase to extend both the 5'
and the 3' fragments generated by cleavage, we propose two general
models. The first model postulates two distinct active sites for the RT
and nuclease activity in a single polypeptide. These two active sites
are flexibly positioned relative to each other such that following the
cleavage reaction, the RT domain can stochastically interact with and
extend either the 5'- or the 3'-end fragment (Fig.
8A). Existing biochemical data suggest that the telomerase complex can interact with an extended region of the
DNA primer, from the 3' end where polymerization takes place, to
approximately 25 nt upstream. Thus, both the 5' and the 3' cleavage
products may remain associated with the complex and serve as substrates
for extension. This general model is consistent with an earlier study
by Greene et al. (10) showing a flexible relationship
between the nuclease and RT of telomerase. An implication of this model
is that a single complex cannot extend both cleavage products
simultaneously.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 8.
Models for telomerase-mediated cleavage-extension
reactions. (A) Telomerase is shown to possess two distinctive active
sites for nuclease (NU) and RT activity. Following cleavage, the RT
domain can capture stochastically either the 5'-end fragment (5'F) or
the 3'-end fragment (3'F) for extension. (B) Telomerase is shown to be
a dimeric enzyme containing two active sites. Each active site is
bifunctional and capable of mediating both primer cleavage and
extension (NU/RT). Following cleavage of the starting primer by one of
the protomers, the resulting 5'-end fragment (5'F) and 3'-end fragment
(3'F) can both be extended because of the presence of the two
bifunctional active sites.
|
|
A second plausible model invokes a single active site that mediates
both cleavage and extension but postulates that yeast telomerase is
multimeric (Fig. 8B). If, for example, telomerase is a dimer, then one
protomer can be acting as a nuclease. Following cleavage, this protomer
would be ideally positioned to extend the 5' fragment, while the other
protomer can capture the 3' fragment for extension. In this fashion, a
single telomerase complex would be capable of elongating both cleavage
products. Consistent with this second model are recently published
experimental results showing that yeast telomerase may indeed be
multimeric (30). Our two general models are not mutually
exclusive, and features of both may be combined. For example, a
multimeric telomerase containing distinct nuclease and RT active sites
would also be consistent with our experimental results. Clearly, more
analysis is necessary to determine the molecular coupling mechanisms
between the nuclease and RT of telomerase.
The function of telomerase-associated nuclease remains to be
elucidated. That a nonciliate telomerase can be shown to possess a
tightly associated nuclease activity indicates that the latter is not
likely to be exclusively involved in developmentally mediated chromosome fragmentation. Otherwise, our data are compatible with previously proposed functions, such as enhancing the fidelity of DNA
synthesis and enhancing elongation efficiency. Another speculative
function for the nuclease is raised by our finding that telomerase may
be engaged with the 3' fragment following cleavage (Fig. 8A). Cleavage
in this case can result in the release of the enzyme from telomeric
ends and completely abort the elongation of chromosomes. This may be
one way of negatively regulating the action of the enzyme. (Extension
of the released 3' fragment would not appear to have any physiologic
significance and may simply be an unintended consequence of the
cleavage reaction.) Continued analysis of the telomerase-associated
nuclease in a genetically tractable organism may eventually allow these
proposed functions to be tested in vivo.
 |
ACKNOWLEDGMENTS |
We thank B. Futcher, B. Schneider, and B. Schwer for strains and
plasmids and D. Shippen for communicating unpublished results.
This work was supported by an American Cancer Society research grant
and a U.S. Army Breast Cancer Idea Award.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, W. R. Hearst Microbiology Research
Center, Weill Medical College of Cornell University, 1300 York Ave.,
New York, NY 10021. Phone: (212) 746-6506. Fax: (212) 746-8587. E-mail: nflue{at}mail.med.cornell.edu.
 |
REFERENCES |
| 1.
|
Blackburn, E. H., and C. W. Greider.
1995.
Telomeres.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 2.
|
Blackburn, E. H.
1992.
Telomerases.
Annu. Rev. Biochem.
61:113-129[CrossRef][Medline].
|
| 3.
|
Bryan, T. M.,
J. M. Sperger,
K. B. Chapman, and T. R. Cech.
1998.
Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytrica trifallax.
Proc. Natl. Acad. Sci. USA
95:8479-8484[Abstract/Free Full Text].
|
| 4.
|
Cohn, M., and E. H. Blackburn.
1995.
Telomerase in yeast.
Science
269:396-400[Abstract/Free Full Text].
|
| 5.
|
Collins, K., and L. Gandhi.
1998.
The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex.
Proc. Natl. Acad. Sci. USA
95:8485-8490[Abstract/Free Full Text].
|
| 6.
|
Collins, K., and C. W. Greider.
1993.
Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation.
Genes Dev.
7:1364-1376[Abstract/Free Full Text].
|
| 7.
|
Collins, K.,
R. Kobayashi, and C. W. Greider.
1995.
Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme.
Cell
81:677-686[CrossRef][Medline].
|
| 8.
|
Feng, J.,
W. D. Funk,
S.-S. Wang,
S. L. Weinrich,
A. A. Avillion,
C.-P. Chiu,
R. R. Adams,
E. Chang,
R. C. Allsopp,
J. Yu,
S. Le,
M. D. West,
C. B. Harley,
W. H. Andrews,
C. W. Greider, and B. Villeponteau.
1995.
The RNA component of human telomerase.
Science
269:1236-1241[Abstract/Free Full Text].
|
| 9.
|
Gandhi, L., and K. Collins.
1998.
Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates.
Genes Dev.
12:721-733[Abstract/Free Full Text].
|
| 10.
|
Greene, E. C.,
J. Bednenko, and D. E. Shippen.
1998.
Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA.
Mol. Cell. Biol.
18:1544-1552[Abstract/Free Full Text].
|
| 11.
|
Greider, C. W., and E. H. Blackburn.
1985.
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.
Cell
43:405-413[CrossRef][Medline].
|
| 12.
|
Greider, C. W., and E. H. Blackburn.
1989.
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.
Nature
337:331-337[CrossRef][Medline].
|
| 13.
|
Greider, C. W.
1991.
Telomerase is processive.
Mol. Cell. Biol.
11:4572-4580[Abstract/Free Full Text].
|
| 14.
|
Hammond, P. W., and T. R. Cech.
1997.
dGTP-dependent processivity and possible template switching of Euplotes telomerase.
Nucleic Acids Res.
25:3698-3704[Abstract/Free Full Text].
|
| 15.
|
Harrington, L.,
T. McPhail,
V. Mar,
W. Zhou,
R. Oulton Amgen EST Program,
M. B. Bass,
I. Arruda, and M. O. Robinson.
1997.
A mammalian telomerase-associated protein.
Science
275:973-977[Abstract/Free Full Text].
|
| 16.
|
Lendvay, T. S.,
D. K. Morris,
J. Sah,
B. Balasubramanian, and V. Lundblad.
1996.
Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes.
Genetics
144:1399-1412[Abstract].
|
| 17.
|
Lin, J.-J., and V. Zakian.
1995.
An in vitro assay for Saccharomyces telomerase requires EST1.
Cell
81:1127-1135[CrossRef][Medline].
|
| 18.
|
Lingner, J.,
T. R. Hughes,
A. Shevchenko,
M. Mann,
V. Lundblad, and T. R. Cech.
1997.
Reverse transcriptase motifs in the catalytic subunit of telomerase.
Science
276:561-567[Abstract/Free Full Text].
|
| 19.
|
Lingner, J.,
T. R. Cech,
T. R. Hughes, and V. Lundblad.
1997.
Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity.
Proc. Natl. Acad. Sci. USA
94:11190-11195[Abstract/Free Full Text].
|
| 20.
|
Lue, N. F., and Y. Peng.
1997.
Identification and characterization of a telomerase activity from Schizosaccharomyces pombe.
Nucleic Acids Res.
25:4331-4337[Abstract/Free Full Text].
|
| 21.
|
Lue, N. F., and Y. Peng.
1998.
Negative regulation of yeast telomerase activity through an interaction with an upstream region of the DNA primer.
Nucleic Acids Res.
26:1487-1494[Abstract/Free Full Text].
|
| 22.
|
Mantell, L. L., and C. W. Greider.
1994.
Telomerase activity in germline and embryonic cells of Xenopus.
EMBO
13:3211-3213[Medline].
|
| 23.
|
Melek, M.,
E. C. Greene, and D. E. Shippen.
1996.
Processing of nontelomeric 3' ends by telomerase: default template alignment and endonucleolytic cleavage.
Mol. Cell. Biol.
16:3437-3445[Abstract].
|
| 24.
|
Meyerson, M.,
C. M. Counter,
E. N. Eaton,
L. W. Ellisen,
P. Steiner,
S. D. Caddle,
L. Ziaugra,
R. L. Beijersbergen,
M. J. Davidoof,
Q. Liu, et al.
1997.
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.
Cell
90:785-795[CrossRef][Medline].
|
| 25.
|
Morin, G.
1989.
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.
Cell
59:521-529[CrossRef][Medline].
|
| 26.
|
Nakamura, T. M.,
G. B. Morin,
K. B. Chapman,
S. L. Weinrich,
W. H. Andrews,
J. Lingner,
C. B. Harley, and T. R. Cech.
1997.
Telomerase catalytic subunit homologs from fission yeast and human.
Science
277:955-959[Abstract/Free Full Text].
|
| 27.
|
Nakayama, J.-I.,
M. Saito,
H. Nakamura,
A. Matsuura, and F. Ishikawa.
1997.
TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family.
Cell
88:875-884[CrossRef][Medline].
|
| 28.
|
Nugent, C. I., and V. Lundblad.
1998.
The telomerase reverse transcriptase: components and regulation.
Genes Dev.
12:1073-1085[Free Full Text].
|
| 29.
|
Prescott, J., and E. H. Blackburn.
1997.
Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal non-processivity in vivo and in vitro.
Genes Dev.
11:528-540[Abstract/Free Full Text].
|
| 30.
|
Prescott, J., and E. H. Blackburn.
1997.
Functionally interacting telomerase RNAs in the yeast telomerase complex.
Genes Dev.
11:2790-2800[Abstract/Free Full Text].
|
| 31.
|
Prowse, K. R.,
A. A. Avilion, and C. W. Greider.
1993.
Identification of a nonprocessive telomerase activity from mouse cells.
Proc. Natl. Acad. Sci. USA
90:1493-1497[Abstract/Free Full Text].
|
| 32.
|
Rudd, M. D.,
M. G. Izban, and D. S. Luse.
1994.
The active site of RNA polymerase II participates in transcript cleavage within arrested ternary complexes.
Proc. Natl. Acad. Sci. USA
91:8057-8061[Abstract/Free Full Text].
|
| 33.
|
Schneider, B. L.,
W. Seufert,
B. Steiner,
Q. H. Yang, and A. B. Futcher.
1995.
Use of polymerase chain reaction epitope tagging for protein tagging in Saccharomyces cerevisiae.
Yeast
11:1265-1274[CrossRef][Medline].
|
| 34.
|
Singer, M. S., and D. E. Gottschling.
1994.
TLC1:template RNA component of Saccharomyces cerevisiae telomerase.
Science
266:404-409[Abstract/Free Full Text].
|
| 35.
|
Steiner, B. R.,
K. Hidaka, and B. Futcher.
1996.
Association of the Est1 protein with telomerase activity in yeast.
Proc. Natl. Acad. Sci. USA
93:2817-2821[Abstract/Free Full Text].
|
| 36.
|
Uptain, S. M.,
C. M. Kane, and M. J. Chamberlin.
1997.
Basic mechanisms of transcription elongation and its regulation.
Annu. Rev. Biochem.
66:117-172[CrossRef][Medline].
|
| 37.
|
Zakian, V. A.
1995.
Telomeres: beginning to understand the end.
Science
270:1601-1607[Abstract/Free Full Text].
|
Molecular and Cellular Biology, September 2000, p. 6806-6815, Vol. 20, No. 18
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Oulton, R., Harrington, L.
(2004). A Human Telomerase-associated Nuclease. Mol. Biol. Cell
15: 3244-3256
[Abstract]
[Full Text]
-
Huard, S., Autexier, C.
(2004). Human telomerase catalyzes nucleolytic primer cleavage. Nucleic Acids Res
32: 2171-2180
[Abstract]
[Full Text]
-
Underwood, D. H., Zinzen, R. P., McEachern, M. J.
(2004). Template Requirements for Telomerase Translocation in Kluyveromyces lactis. Mol. Cell. Biol.
24: 912-923
[Abstract]
[Full Text]
-
SETO, A. G., UMANSKY, K., TZFATI, Y., ZAUG, A. J., BLACKBURN, E. H., CECH, T. R.
(2003). A template-proximal RNA paired element contributes to Saccharomyces cerevisiae telomerase activity. RNA
9: 1323-1332
[Abstract]
[Full Text]
-
Huard, S., Moriarty, T. J., Autexier, C.
(2003). The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity. Nucleic Acids Res
31: 4059-4070
[Abstract]
[Full Text]
-
Beattie, T. L., Zhou, W., Robinson, M. O., Harrington, L.
(2001). Functional Multimerization of the Human Telomerase Reverse Transcriptase. Mol. Cell. Biol.
21: 6151-6160
[Abstract]
[Full Text]
-
Ray, A., Runge, K. W.
(2001). Yeast telomerase appears to frequently copy the entire template in vivo. Nucleic Acids Res
29: 2382-2394
[Abstract]
[Full Text]